CANSLIM Stock Screener – 2026-09-01 (128 Stocks)

The scan for 2026-09-01 selected 128 stocks in total. Software-related sectors dominate the list, with Software – Application contributing 32 names and Software – Infrastructure contributing 27 names. Oil & Gas Refining & Marketing is a distant third with 8 names, indicating a clear technology-heavy tilt in the current market leadership.

Ten stocks passed two or more screening criteria, which marks the strongest level of confirmation in this scan. These names are ANET, BRZE, CRM, ETON, NET, PLTR, RBRK, S, SNOW, and TEAM. This multi-screen overlap suggests these issues exhibit a broader set of qualifying characteristics than the rest of the field, making them stand out within the CAN SLIM stock screener framework.

Among the newly added names, CDW, FTNT, GDDY, KVYO, LPG, PAYC, PI, REPX, SAIL, and TYL entered the list for the first time relative to the prior trading day. Meanwhile, a larger group of 23 names dropped out, including AU, AYA, BDSX, BSP, CTSH, DAVE, DBX, ENVA, ETSY, FIG, FRO, FSLY, GLBE, IOT, MNDY, PCOR, SE, SHIP, TECK, URBN, URGN, VSXY, XMTR, and ZD. The churn reflects a tightening of the technical criteria, where only those CANSLIM stocks with the most constructive price and volume patterns maintained their standing.

For educational purposes only — not investment advice.


Discover more from CANSLIM Research

Subscribe to get the latest posts sent to your email.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.

Discover more from CANSLIM Research

Subscribe now to keep reading and get access to the full archive.

Continue reading